Halder Venture Approves Auditor Changes, Capital Increase, and Warrant Issue
Halder Venture Limited's board approved the resignation of its internal auditor and appointed a new one. The company will increase its authorized share capital and issue 7,93,650 warrants at ₹315 each to P.K. Bio Link Private Limited and others, raising approximately ₹24.99 crore. Shareholder approval is pending via postal ballot.
The increase in authorized capital and the issuance of warrants are significant corporate actions that could impact the company's financial structure and future equity. The appointment of a new auditor is a routine but important operational update.
The company is taking proactive steps by appointing a new auditor and increasing its capital, along with issuing warrants, which indicates potential growth and financial strengthening.
Halder Venture Limited's Board of Directors met on March 26, 2026, approving several key resolutions. The board accepted the resignation of Internal Auditor M/s Somnath Ray & Associates and appointed M/s J Kumar Jain & Associates as the new Internal Auditor for the Financial Year 2025-2026.
Furthermore, the board consented to an increase in the company's authorized share capital from ₹13,42,50,000 to ₹18,42,50,000, involving the creation of an additional 50,00,000 equity shares of ₹10 each. This change in the Memorandum of Association is subject to shareholder approval via postal ballot.
In a significant move, the company also approved the creation, issue, and offer of 7,93,650 convertible warrants. Each warrant has a face value of ₹10 and is offered at ₹315 (including a premium of ₹305). These warrants are convertible into one fully paid-up equity share and will be issued to specified persons/entities, including P.K. Bio Link Private Limited, subject to shareholder approval through postal ballot. The total amount raised from this warrant issue is approximately ₹24,99,99,750. The company also approved the notice for the postal ballot to seek shareholder consent for these proposals.
What to do with a filing like this
Halder Venture Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Halder Venture Limited. Read the original for the full detail.